The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis
Fa-Jun Xie,1,2 Hong-Yang Lu,1,3 Qiu-Qing Zheng,3 Jing Qin,1,3 Yun Gao,3 Yi-Ping Zhang,1,3 Xun Hu,2 Wei-Min Mao3,4 1Department of Medical Oncology, Zhejiang Cancer Hospital, 2Cancer Institute (Key Laboratory for Cancer Intervention and Prevention, China National Ministry of Education, Zhejiang Provi...
Main Authors: | Xie FJ, Lu HY, Zheng QQ, Qin J, Gao Y, Zhang YP, Hu X, Mao WM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2016-01-01
|
Series: | OncoTargets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/the-clinical-pathological-characteristics-and-prognosis-of-fgfr1-gene--peer-reviewed-article-OTT |
Similar Items
-
FGFR1 amplification or overexpression and hormonal resistance in luminal breast cancer: rationale for a triple blockade of ER, CDK4/6, and FGFR1
by: Silvana Mouron, et al.
Published: (2021-02-01) -
FGFR2 amplification is predictive of sensitivity to regorafenib in gastric and colorectal cancers in vitro
by: Yongjun Cha, et al.
Published: (2018-06-01) -
FGFR-1 amplification in metastatic lymph-nodal and haematogenous lobular breast carcinoma
by: Brunello Eleonora, et al.
Published: (2012-12-01) -
Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases
by: Zhen Zhou, et al.
Published: (2021-05-01) -
Novel targetable FGFR2 and FGFR3 alterations in glioblastoma associate with aggressive phenotype and distinct gene expression programs
by: Maria-Magdalena Georgescu, et al.
Published: (2021-04-01)